Susquehanna International Group, LLP Vericel Corp Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Vericel Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 62,459 shares of VCEL stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,459
Previous 69,652
10.33%
Holding current value
$2.09 Million
Previous $3.11 Million
14.48%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$119 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$94.2 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$82.5 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$81.6 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.58B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...